Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
Clinical trial NCT00087022 · COMPLETED
Trial details
- NCT number
- NCT00087022
- Sponsor
- Heidelberg Pharma AG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2012-10-01
- Enrollment
- 864
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.